Menta Capital’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Menta Capital’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$1.31M	Buy	15,320 +8,440	+123%	+$835K	0.56%	10
2019 Q1	$744K	Buy	+6,880	New	+$685K	0.33%	101
2015 Q3	–	Sell	-10,136	Closed	-$1.46M	–	829
2015 Q2	$1.46M	Hold	10,136	–	–	0.24%	137
2015 Q1	$1.43M	Buy	10,136 +6,415	+172%	+$987K	0.18%	185
2014 Q4	$551K	Sell	3,721 -980	-21%	-$144K	0.08%	392
2014 Q3	$723K	Hold	4,701	–	–	0.12%	273
2014 Q2	$659K	Buy	4,701 +340	+8%	+$37.7K	0.12%	233
2014 Q1	$484K	Hold	4,361	–	–	0.14%	199
2013 Q4	$431K	Hold	4,361	–	–	0.18%	182
2013 Q3	$331K	Hold	4,361	–	–	0.17%	203
2013 Q2	$244K	Buy	+4,361	New	+$258K	0.16%	273

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CAM

Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return

Menta Capital's TARO Position: Q2 2019 in Review

Menta Capital increased its Taro Pharmaceutical Industries Ltd. (TARO) stake by 123% in Q2 2019, buying an estimated $835K and bringing the position to 15,320 shares worth $1.31M. The position accounts for 0.56% of the portfolio, ranked #10.

Menta Capital first reported a position in TARO in Q2 2013 and has held it in 11 quarters since. The position peaked at $1.46M in Q2 2015. 105 funds tracked by Wall St. Rank hold TARO as of Q2 2019.

Menta Capital held 15,320 shares of Taro Pharmaceutical Industries Ltd. worth $1.31M as of Q2 2019.
Menta Capital bought 8,440 Taro Pharmaceutical Industries Ltd. shares in Q2 2019, an estimated $835K.
Taro Pharmaceutical Industries Ltd. made up 0.56% of Menta Capital's portfolio in Q2 2019, its #10 holding.
Menta Capital first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2013 and has held it in 11 quarters since.
Menta Capital's Taro Pharmaceutical Industries Ltd. position peaked at $1.46M in Q2 2015.
105 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2019.

Based on Menta Capital's 13F filing for Q2 2019, filed 7 Aug 2019.